Abstract
Amyvid (florbetapir f18, [F-18]AV-45, [F-18]5) was the first FDA-approved positron emission tomography imaging agent targeting beta-amyloid (A beta) p......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
